Depomed Revises Protocol For Gabapentin GR Postherpetic Neuralgia Phase III
This article was originally published in The Pink Sheet Daily
Executive Summary
After the initial Phase III trial of the extended-release drug failed to show a benefit over placebo in PHN, Depomed gives it another go.